In order to determine the causes of treatment failure in community-acquired pneumonia (CAP) clinical trials, a MEDLINE search for all CAP studies published between 1990 and 1997 was performed. Prospective, randomized studies comparing the efficacy of two or more antibiotics in CAP were selected. Treatment failure was defined as persistent fever, deterioration of patient's condition, or a change in the prescribed antibiotic regimen. In 16% of the cases included in the clinical trials, the treatment of CAP is unsuccessful. A significant number of identified failure cases were owing to antibiotic side-effects. Resistant pathogens are an unusual cause of failure whatever the antibiotic used
Community-acquired pneumonia (CAP) is the leading cause of death among infectious diseases and an im...
Background/aim: The optimal empiric antibiotic regimen for patients with community-acquired pneumoni...
Community-acquired pneumonia (CAP) is common, and inpatient physicians should be familiar with the m...
In order to determine the causes of treatment failure in community-acquired pneumonia (CAP) clinical...
Once antibiotics have been started in patients with community-acquired pneumonia (CAP), the evaluati...
International audienceImportance: Failure of treatment is the most serious complication in community...
To determine the causes of treatment failure and to evaluate the prognostic factors in patients hosp...
Background: The etiology of clinical failure in hospitalized patients with community-acquired pneumo...
Background/aim: Treatment failure in hospitalized patients with community-acquired pneumonia is a ma...
Background A considerable percentage of empirical antibiotic treatment fails in hospitalized patient...
Antimicrobial therapy is the mainstay of management for community-acquired pneumonia (CAP). Accordin...
INTRODUCTION: Treatment failure in community-acquired-pneumonia (CAP) patients is associated with a ...
At the time of diagnosis in patients with community-acquired pneumonia, the causative pathogen is ra...
Community-acquired pneumonia (CAP) has an annual incidence of 2 to 10‰ that increases with advancing...
Community-acquired pneumonia (CAP) is a common disorder that has been the focus of a major internati...
Community-acquired pneumonia (CAP) is the leading cause of death among infectious diseases and an im...
Background/aim: The optimal empiric antibiotic regimen for patients with community-acquired pneumoni...
Community-acquired pneumonia (CAP) is common, and inpatient physicians should be familiar with the m...
In order to determine the causes of treatment failure in community-acquired pneumonia (CAP) clinical...
Once antibiotics have been started in patients with community-acquired pneumonia (CAP), the evaluati...
International audienceImportance: Failure of treatment is the most serious complication in community...
To determine the causes of treatment failure and to evaluate the prognostic factors in patients hosp...
Background: The etiology of clinical failure in hospitalized patients with community-acquired pneumo...
Background/aim: Treatment failure in hospitalized patients with community-acquired pneumonia is a ma...
Background A considerable percentage of empirical antibiotic treatment fails in hospitalized patient...
Antimicrobial therapy is the mainstay of management for community-acquired pneumonia (CAP). Accordin...
INTRODUCTION: Treatment failure in community-acquired-pneumonia (CAP) patients is associated with a ...
At the time of diagnosis in patients with community-acquired pneumonia, the causative pathogen is ra...
Community-acquired pneumonia (CAP) has an annual incidence of 2 to 10‰ that increases with advancing...
Community-acquired pneumonia (CAP) is a common disorder that has been the focus of a major internati...
Community-acquired pneumonia (CAP) is the leading cause of death among infectious diseases and an im...
Background/aim: The optimal empiric antibiotic regimen for patients with community-acquired pneumoni...
Community-acquired pneumonia (CAP) is common, and inpatient physicians should be familiar with the m...